Columbia Sportswear (COLM) Q4 2025 earnings review
International Strength Masks U.S. Decline and Tariff Pain
Columbia delivered a mixed Q4 where international momentum saved the quarter from a domestic collapse. While total revenue dipped 2% to $1.07B, the divergence is stark: International markets grew across the board (EMEA +8%, LAAP +8%), while the core U.S. market fell 8%. Management touted 'healthier inventory' (units down 11%), which aided gross margins in Q4, but the forward look is sober. Tariffs are expected to inflict a ~300 basis point hit to gross margin in FY26, and the Q1 2026 outlook projects a sharp earnings contraction (-61% EPS at midpoint). The company is betting heavily on its 'ACCELERATE' marketing strategy to fix U.S. demand, but the immediate financial reality is a struggle against policy headwinds and consumer fatigue.
🐂 Bull Case
The brand travels well. Europe (EMEA) and Asia (LAAP) grew 8% each in Q4, proving that product appeal remains high outside the saturated U.S. market. International now comprises a larger mix, providing a hedge against U.S. macro weakness.
Management successfully reset the balance sheet. Inventory units are down 11% YoY, and clearance activity was lower in Q4, allowing Gross Margin to expand 50bps to 51.6% despite tariff headwinds.
🐻 Bear Case
The core U.S. business is shrinking, accelerating from -1% in Q1 to -8% in Q4. This isn't just wholesale timing; it reflects genuine demand softness in the largest revenue region.
The FY26 outlook includes a massive ~300 basis point gross margin headwind from unmitigated tariffs. Pricing power to offset this in a deflationary apparel market is unproven.
⚖️ Verdict: 🔴
Bearish. While the balance sheet is a fortress (zero debt, ~$790M cash), the earnings quality is deteriorating. The U.S. business is shrinking, SOREL is in freefall, and the Q1 2026 guidance implies a brutal start to the year. The stock is a 'show me' story on U.S. stabilization.
Key Themes
Tariff Impact: The $300bps Hit
Management was explicit about the pain from trade policy. FY26 gross margin is guided down to 49.8%-50.0% (vs 50.5% in FY25), driven by a 'roughly 300 basis point unfavorable impact' from incremental tariffs. While they plan to raise prices, the Q1 guidance suggests they are eating the costs early in the year before price hikes stick.
U.S. Wholesale & DTC Weakness
The U.S. market is Reversing. Sales fell 8% in Q4. While part of this was attributed to 'earlier shipment of Fall '25 wholesale orders' shifting out of Q4, U.S. Direct-to-Consumer (DTC) remains challenged. The guidance for Q1 2026 implies a continued decline (-2.5% to -4.0% total company sales), heavily weighted towards U.S. weakness.
SOREL Brand Collapse
The SOREL brand continues to be a major drag, declining 18% in Q4 (19% constant currency). This follows a year of double-digit declines (FY25 -7%). The 'stabilization' narrative from prior quarters has not materialized into numbers yet.
International Diversification
International markets are Accelerating or Stable at high levels. Latin America/Asia Pacific (LAAP) grew 8% and EMEA grew 8% in Q4. China and Europe-direct markets are specifically cited as outperformers. This geographic diversification is the only thing keeping total revenue flat rather than negative.
Inventory Health Improvement
A bright spot in operations: Inventory units decreased ~11% YoY. This 'healthier inventory composition' led to less clearance activity in Q4, boosting gross margins by 50bps. This positions the company well to bring in new Spring product without an overhang of old stock.
SG&A Bloat vs. 'Profit Improvement'
Despite a 'Profit Improvement Program' reducing supply chain costs, SG&A rose 3% in Q4 and deleveraged to 41.3% of sales (vs 39.3%). The culprit: Higher DTC expenses and 'non-recurring SG&A' related to the cost-cutting program itself. Management guides FY26 SG&A to remain high (43.6%-44.2%), signaling difficulty in cutting costs as fast as sales are stagnating.
Other KPIs
Stable. Down slightly from $815.5M last year, but the company remains debt-free. This 'fortress balance sheet' is critical for weathering the tariff storm and allowing for buybacks ($201M repurchased in FY25).
Decelerating significantly from $491.0M in FY24 (-42%). While net income dropped, working capital changes (inventory timing and tax payments) also weighed on cash generation.
Deteriorating. Down from 8.0% in FY24 and 8.9% in FY23. The combination of fixed cost leverage deleverage and impairment charges is compressing profitability to historical lows.
Guidance
Stable/Slight Acceleration. Represents +1.0% to +3.0% growth vs FY25. This assumes international strength offsets U.S. stagnation. Management cites 'foreign currency benefit' of 50-100 bps, meaning organic growth is very low.
Stagnant. At the midpoint ($3.425), this is roughly +5% vs FY25's $3.24. However, considering FY25 included $0.45 of impairment charges, the 'clean' operational earnings power is actually guided down.
Decelerating. Represents a decline of 2.5% to 4.0% YoY. Management blames 'lower Spring '26 orders' in U.S. Wholesale and U.S. DTC weakness.
Collapsing. Compare to $0.75 in Q1 25. This represents a ~50-60% drop in profitability to start the year, driven by unmitigated tariffs hitting gross margin and SG&A deleverage on lower sales.
Key Questions
U.S. Wholesale Bottom
With Q1 26 guided down due to lower Spring orders, and Fall '25 orders cited as having 'earlier shipments' in 25Q4, when does the U.S. wholesale channel actually return to organic unit growth?
Pricing Power in Deflationary Environment
You plan to mitigate tariffs via price increases in FY26. With the U.S. consumer already rejecting your current offering (-8% sales in Q4), what gives you confidence that raising prices won't further compress volume?
SOREL Strategic Review
SOREL has declined double-digits for consecutive quarters (-18% in Q4). Is the brand broken, and would you consider strategic alternatives if 'stabilization' fails in 2026?
SG&A Leverage Timeline
SG&A is guided to 43.6-44.2% for FY26, barely better than FY25's 44.2%. When does the 'Profit Improvement Program' actually yield visible margin expansion, rather than just offsetting inflation?